Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 14, 2016
Total Value: $326M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | 2,810,315 | $44.63M | 13.7% | $9.33 | +25.3% | COM | 46333X108 |
| GLPG | GALAPAGOS NV | 500,576 | $32.37M | 9.9% | $56.91 | — | SPONSORED ADR | 36315X101 |
| — | BRISTOL MYERS SQUIBB CO | 500,000 | $26.96M | 8.3% | — | — | Call | 110122908 |
| — | ASSEMBLY BIOSCIENCES INC | 2,943,164 | $21.22M | 6.5% | $8.38 | — | COM | 045396108 |
| — | DERMIRA INC | 522,000 | $17.65M | 5.4% | $31.44 | — | COM | 24983L104 |
| ARDX | ARDELYX INC | 1,310,023 | $16.95M | 5.2% | $10.48 | 0.0% | COM | 039697107 |
| KURA | KURA ONCOLOGY INC | 2,611,906 | $16.32M | 5.0% | $10.12 | -49.9% | COM | 50127T109 |
| — | FIVE PRIME THERAPEUTICS INC | 286,612 | $15.04M | 4.6% | $52.49 | — | COM | 33830X104 |
| — | FIBROGEN INC | 686,184 | $14.2M | 4.4% | $24.72 | — | COM | 31572Q808 |
| — | GILEAD SCIENCES INC | 150,000 | $11.87M | 3.6% | — | — | Call | 375558903 |
| — | ALLERGAN PLC | 50,000 | $11.52M | 3.5% | — | — | Call | G0177J908 |
| AGIO | AGIOS PHARMACEUTICALS INC | 200,000 | $10.56M | 3.2% | $43.55 | 0.0% | COM | 00847X104 |
| — | PROTEOSTASIS THERAPEUTICS INC | 602,315 | $9.39M | 2.9% | $15.59 | — | COM | 74373B109 |
| — | EXACT SCIENCES CORP | 500,000 | $9.285M | 2.8% | — | — | Put | 30063P955 |
| — | ACHAOGEN INC | 1,679,707 | $8.046M | 2.5% | $3.85 | — | COM | 004449104 |
| CYTK | CYTOKINETICS INC | 846,654 | $7.772M | 2.4% | $9.00 | +16.0% | COM | 23282W605 |
| — | KINDRED BIOSCIENCES INC | 1,432,765 | $7.149M | 2.2% | $7.10 | — | COM | 494577109 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 357,365 | $5.418M | 1.7% | $12.54 | +4.9% | COM | 87164F105 |
| ONC | BEIGENE LTD | 163,470 | $5.037M | 1.5% | $29.75 | — | SPONSORED ADR | 07725L102 |
| — | IRONWOOD PHARMACEUTICALS INC | 281,500 | $4.47M | 1.4% | — | — | Call | 46333X908 |
| ASND | ASCENDIS PHARMA A S | 219,200 | $4.406M | 1.4% | $20.10 | — | SPONSORED ADR | 04351P101 |
| — | SPARK THERAPEUTICS INC | 68,600 | $4.12M | 1.3% | $60.06 | — | COM | 84652J103 |
| — | ADVERUM BIOTECHNOLOGIES INC | 946,263 | $3.889M | 1.2% | $4.11 | — | COM | 00773U108 |
| — | NABRIVA THERAPEUTICS AG | 548,912 | $3.87M | 1.2% | $9.50 | — | SPONSORED ADR | 62957M104 |
| NTLA | INTELLIA THERAPEUTICS INC | 200,858 | $3.419M | 1.0% | $26.61 | -27.2% | COM | 45826J105 |
| — | CHIMERIX INC | 598,062 | $3.313M | 1.0% | $5.54 | — | COM | 16934W106 |
| — | ONCOMED PHARMACEUTICALS INC | 265,784 | $3.038M | 0.9% | $11.43 | — | COM | 68234X102 |
| FATE | FATE THERAPEUTICS INC | 590,527 | $1.842M | 0.6% | $2.43 | 0.0% | COM | 31189P102 |
| — | CHEMOCENTRYX INC | 178,000 | $1.075M | 0.3% | $6.04 | — | COM | 01683L106 |
| — | SYROS PHARMACEUTICALS INC | 63,596 | $882K | 0.3% | $13.87 | — | COM | 87184Q107 |
| — | CASCADIAN THERAPEUTICS INC | 103,800 | $170K | 0.1% | — | — | Call | 14740B901 |